Roger Henriksson,

Roger Henriksson,'s AcademicInfluence.com Rankings

Roger Henriksson,

Medical

#2804

World Rank

#3241

Historical Rank

Oncology

#181

World Rank

#187

Historical Rank

medical Degrees

Roger Henriksson,

Philosophy

#8014

World Rank

#11313

Historical Rank

Logic

#5053

World Rank

#6412

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Roger Henriksson, Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roger Henriksson,'s Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. (2014) (1957)
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial. (2012) (1019)
Genome-wide association study identifies five susceptibility loci for glioma (2009) (781)
European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas. (2017) (736)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma. (2014) (601)
EANO guidelines for the diagnosis and treatment of meningiomas. (2016) (524)
Detectable clonal mosaicism and its relationship to aging and cancer (2012) (512)
Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. (2001) (373)
LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation (2004) (315)
Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. (2015) (303)
Vascular endothelial growth factor is of high prognostic value in node-negative breast carcinoma. (1998) (277)
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer. (2012) (268)
Correlation of vascular endothelial growth factor content with recurrences, survival, and first relapse site in primary node-positive breast carcinoma after adjuvant treatment. (2000) (263)
Parotid gland function during and following radiotherapy of malignancies in the head and neck. A consecutive study of salivary flow and patient discomfort. (1992) (258)
Patients With Proneural Glioblastoma May Derive Overall Survival Benefit From the Addition of Bevacizumab to First-Line Radiotherapy and Temozolomide: Retrospective Analysis of the AVAglio Trial. (2015) (244)
Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis (2005) (238)
Genome-wide association study of glioma and meta-analysis (2012) (225)
Breast cancer survival is associated with telomere length in peripheral blood cells. (2008) (176)
Cloning, characterization, and expression of human LIG1. (2001) (175)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. (2017) (171)
p53 and vascular‐endothelial‐growth‐factor (VEGF) expression predicts outcome in 833 patients with primary breast carcinoma (2000) (167)
European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. (2017) (160)
The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer. (2001) (157)
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review (2011) (151)
Epidermal growth factor receptor family (EGFR, ErbB2–4) in gliomas and meningiomas (2004) (148)
Polymorphisms in predicted microRNA-binding sites in integrin genes and breast cancer: ITGB4 as prognostic marker. (2008) (148)
The creation of protection and hope in patients with malignant brain tumours. (1996) (146)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. (2015) (133)
Baseline Levels of Glucose Metabolites, Glutamate and Glycerol in Malignant Glioma Assessed by Stereotactic Microdialysis (2004) (125)
The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea. (2004) (121)
Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. (1992) (119)
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA). (2006) (115)
Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus (2010) (113)
Genetic epidemiology of glioma (2001) (111)
Effects of ongoing smoking on the development of radiation-induced pneumonitis in breast cancer and oesophagus cancer patients. (1998) (108)
Familial aggregation of astrocytoma in northern Sweden: An epidemiological cohort study (1999) (106)
Is LRIG1 a Tumour Suppressor Gene at Chromosome 3p14.3? (2002) (103)
Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden (2003) (102)
Health-Related Quality of Life in a Randomized Phase III Study of Bevacizumab, Temozolomide, and Radiotherapy in Newly Diagnosed Glioblastoma. (2015) (101)
LRIG inhibitors of growth factor signalling - double-edged swords in human cancer? (2007) (95)
Characterization of large structural genetic mosaicism in human autosomes. (2015) (91)
Characterization and tissue-specific expression of human LRIG2. (2004) (89)
Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. (2014) (88)
LRIG1 and squamous epithelial uterine cervical cancer: correlation to prognosis, other tumor markers, sex steroid hormones, and smoking (2007) (87)
Cancer patients’ use of complementary and alternative medicine in Sweden: a cross-sectional study (2019) (85)
EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours. (2017) (85)
Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors (2006) (84)
LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–PCR and immunohistochemical analysis (2003) (83)
Familial brain tumours—genetics or environment? A nationwide cohort study of cancer risk in spouses and first‐degree relatives of brain tumour patients (2003) (82)
Pathways from symptoms to medical care: a descriptive study of symptom development and obstacles to early diagnosis in brain tumour patients. (1999) (80)
Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. (2008) (78)
ADC texture--an imaging biomarker for high-grade glioma? (2014) (76)
Effects of smoking and irradiated volume on inflammatory response in the lung of irradiated breast cancer patients evaluated with bronchoalveolar lavage. (1990) (75)
Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome (2016) (72)
A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk (2010) (71)
Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma. (2016) (71)
LRIG1 protein in human cells and tissues (2003) (71)
Hypofractionated Conformal Stereotactic Radiotherapy for Arteriovenous Malformations (2003) (70)
Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study. (1995) (68)
Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancers. (2003) (68)
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer. (2004) (67)
A non-invasive method for fractionated stereotactic irradiation of brain tumors with linear accelerator. (1990) (67)
World Congress Integrative Medicine & Health 2017: Part one (2017) (65)
Genetic variation in p53 and ATM haplotypes and risk of glioma and meningioma (2007) (64)
Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? (1999) (64)
Functional Polymorphisms in Folate Metabolism Genes Influence the Risk of Meningioma and Glioma (2008) (63)
Parotid saliva composition during and after irradiation of head and neck cancer. (1994) (63)
Swedish lung cancer radiation study group: the prognostic value of anaemia, thrombocytosis and leukocytosis at time of diagnosis in patients with non-small cell lung cancer (2012) (62)
An International Case-Control Study of Interleukin-4Rα, Interleukin-13, and Cyclooxygenase-2 Polymorphisms and Glioblastoma Risk (2007) (62)
Increase in doxorubicin cytotoxicity by carvedilol inhibition of P-glycoprotein activity. (1999) (60)
Increase in mast cells and hyaluronic acid correlates to radiation-induced damage and loss of serous acinar cells in salivary glands: the parotid and submandibular glands differ in radiation sensitivity. (1994) (60)
Comprehensive analysis of DNA repair gene variants and risk of meningioma. (2008) (59)
Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases. (2005) (58)
A randomised placebo controlled study with ondansetron in patients undergoing fractionated radiotherapy. (1996) (56)
Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival (2009) (56)
LRIG and cancer prognosis (2014) (54)
An International Case-Control Study of Glutathione Transferase and Functionally Related Polymorphisms and Risk of Primary Adult Brain Tumors (2007) (54)
Glioblastoma (GBM) in elderly patients: A randomized phase III trial comparing survival in patients treated with 6-week radiotherapy (RT) versus hypofractionated RT over 2 weeks versus temozolomide single-agent chemotherapy (TMZ). (2010) (54)
The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model (2004) (53)
Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden (2007) (53)
How was life after treatment of a malignant brain tumour? (2000) (52)
Common variation at 10p12.31 near MLLT10 influences meningioma risk (2011) (52)
Brain tumors in Sweden: Data from a population-based registry 1999–2012 (2015) (51)
Validation of postoperative residual contrast-enhancing tumor volume as an independent prognostic factor for overall survival in newly diagnosed glioblastoma (2018) (51)
Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment. (2004) (51)
Heterogeneity in the expression of markers for drug resistance in brain tumors. (2004) (50)
Spatial Expression of VEGF-A in Human Glioma (2002) (50)
Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1. (2011) (49)
LRIG2 in contrast to LRIG1 predicts poor survival in early-stage squamous cell carcinoma of the uterine cervix (2010) (48)
Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen. (1998) (48)
Effects of the VEGFR inhibitor ZD6474 in combination with radiotherapy and temozolomide in an orthotopic glioma model (2008) (48)
LRIG1 and the liar paradox in prostate cancer: A study of the expression and clinical significance of LRIG1 in prostate cancer (2011) (47)
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study (2005) (47)
Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer (2014) (47)
CHARACTERIZATION OF THE RAT PAROTID β‐ADRENOCEPTOR (1981) (46)
The Common D302H Variant of CASP8 Is Associated with Risk of Glioma (2008) (45)
Expression of the proteolytic factors, tPA and uPA, PAI-1 and VEGF during malignant glioma progression (1999) (44)
Genome-wide high-density SNP linkage search for glioma susceptibility loci: results from the Gliogene Consortium. (2011) (44)
Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors. (2012) (44)
Primary brain tumours as second primary: A novel association between meningioma and colorectal cancer (2000) (43)
Induction of apoptosis by intracellular potassium ion depletion: using the fluorescent dye PBFI in a 96-well plate method in cultured lung cancer cells. (2006) (43)
Expression of LRIG1 and LRIG3 correlates with human papillomavirus status and patient survival in cervical adenocarcinoma. (2013) (43)
ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases. (2009) (42)
Mammaglobin in normal human sweat glands and human sweat gland tumors. (2003) (41)
Different Aetiology of Familial Low-Grade and High-Grade Glioma? A Nationwide Cohort Study of Familial Glioma (2002) (41)
Neurosurgical treatment and outcome patterns of meningioma in Sweden: a nationwide registry-based study (2019) (40)
Planning of radiotherapy for patients with hip prosthesis. (1991) (40)
Effects of radiotherapy and estramustine on the microvasculature in malignant glioma (1999) (40)
ErbB4 is downregulated in renal cell carcinoma A quantitative RT-PCR and immunohistochemical analysis of the epidermal growth factor receptor family (2004) (40)
Polymorphisms in telomere-associated genes, breast cancer susceptibility and prognosis. (2009) (39)
Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma (2013) (39)
p53 Genotypes and Risk of Glioma and Meningioma (2005) (39)
Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy (2008) (39)
Severely diseased lung cancer patients narrate the importance of being included in a helping relationship. (2005) (38)
Dysregulated secretoglobin expression in human lung cancers. (2003) (38)
Estramustine binding protein and anti-proliferative effect of estramustine in human glioma cell lines. (1988) (37)
Immunotherapy of metastatic renal cell carcinoma (1997) (37)
Upfront bevacizumab may extend survival for glioblastoma patients who do not receive second-line therapy: an exploratory analysis of AVAglio. (2016) (37)
The effect of ondansetron on radiation-induced emesis and diarrhoea. (1992) (37)
Progression-free survival (PFS) and health-related quality of life (HRQoL) in AVAglio, a phase III study of bevacizumab (Bv), temozolomide (T), and radiotherapy (RT) in newly diagnosed glioblastoma (GBM). (2013) (37)
Acute effects of accelerated radiotherapy in combination with carbogen breathing and nicotinamide (ARCON). (1994) (37)
Fractionated irradiation and early changes in salivary glands. Different effects on potassium efflux, exocytotic amylase release and gland morphology. (1991) (36)
Durable stabilization of three chordoma cases by bevacizumab and erlotinib (2014) (35)
Pronounced substance P innervation in irradiation-induced enteropathy — a study on human colon (2000) (34)
Lrig1 is a haploinsufficient tumor suppressor gene in malignant glioma (2018) (34)
Microsatellite instability, PTEN and p53 germline mutations in glioma families. (2001) (34)
Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival (2011) (34)
LRIG1 expression in colorectal cancer (2007) (34)
Estramustine binding protein in human brain-tumor tissue. (1991) (34)
Tumor response based on adapted Macdonald criteria and assessment of pseudoprogression (PsPD) in the phase III AVAglio trial of bevacizumab (Bv) plus temozolomide (T) plus radiotherapy (RT) in newly diagnosed glioblastoma (GBM). (2013) (34)
Pharmacokinetics and Pharmacodynamics of Estramustine Phosphate (1998) (33)
LRIG1 is a prognostic biomarker in non-small cell lung cancer (2015) (33)
DISSOCIATION OF β‐ADRENOCEPTOR‐INDUCED EFFECTS ON AMYLASE SECRETION AND CYCLIC ADENOSINE 3′,5′‐MONOPHOSPHATE ACCUMULATION (1982) (32)
MNS16A minisatellite genotypes in relation to risk of glioma and meningioma and to glioblastoma outcome (2009) (32)
Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia (2008) (32)
Role of ondansetron plus dexamethasone in fractionated chemotherapy. (1993) (31)
Loss of LRIG1 locus increases risk of early and late relapse of stage I/II breast cancer. (2014) (31)
PAI-1 −675 4G/5G polymorphism as a prognostic biomarker in breast cancer (2008) (31)
Hyaluronan reflects the pre-fibrotic inflammation in irradiated rat lung: concomitant analysis of parenchymal tissues and bronchoalveolar lavage. (1990) (31)
Bevacizumab, temozolomide, and radiotherapy for newly diagnosed glioblastoma: comprehensive safety results during and after first-line therapy. (2016) (31)
Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans. (1993) (31)
Salivary glands in long-term alloxan-diabetic rats. A quantitative light and electron-microscopic study. (2009) (30)
Identification of potassium flux pathways and their role in the cytotoxicity of estramustine in human malignant glioma, prostatic carcinoma and pulmonary carcinoma cell lines. (1994) (30)
Increased copy number at 3p14 in breast cancer (2005) (30)
Bilateral irradiation of head and neck induces an enhanced expression of substance p in the parasympathetic innervation of the submandibular gland (1992) (30)
Prognostic value of O‐6‐methylguanine–DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis (2018) (29)
Redistribution of LRIG proteins in psoriasis. (2008) (29)
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma (2012) (29)
Aspects on reducing gastrointestinal adverse effects associated with radiotherapy. (1999) (29)
Long-term memory deficits in patients with malignant gliomas (2005) (29)
Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma (2000) (29)
EFFECTS OF A NEW SELECTIVE β1‐ADRENOCEPTOR AGONIST ON AMYLASE SECRETION FROM THE RAT PAROTID GLAND (1978) (29)
Single nucleotide polymorphisms in the 20q13 amplicon genes in relation to breast cancer risk and clinical outcome (2011) (28)
Cytotoxic effect and uptake of estramustine in a rat glioma model. (1994) (28)
Genetic variations in VEGF and VEGFR2 and glioblastoma outcome (2010) (28)
Polymorphisms associated with asthma are inversely related to glioblastoma multiforme. (2006) (28)
Cisplatin‐induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide (2001) (27)
How to tell cancer patients : A contribution to a theory of communicating the diagnosis (1999) (27)
Association between adult height, genetic susceptibility and risk of glioma. (2012) (27)
Amphotericin B-induced apoptosis and cytotoxicity is prevented by the Na+, K+, 2Cl(-)-cotransport blocker bumetanide. (2000) (27)
Known glioma risk loci are associated with glioma with a family history of brain tumours—A case–control gene association study (2013) (27)
Age and surgical outcome of low‐grade glioma in Sweden (2018) (27)
A specialist nurse-function in neurooncology: A qualitative study of possibilities, limitations, and pitfalls (2005) (27)
Effects of active addition of bacterial cultures in fermented milk to patients with chronic bowel discomfort following irradiation (2004) (26)
Rehabilitation of patients with glioma. (2016) (26)
Sex steroids in human brain tumors and breast cancer (1990) (26)
Prevention of irradiation-induced bowel discomfort by sucralfate: a double-blind, placebo-controlled study when treating localized pelvic cancer. (1991) (26)
Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer (2012) (26)
Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity (2012) (26)
Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population (2015) (25)
DNA fragmentation induced by the antimitotic drug estramustine in malignant rat glioma but not in normal brain--suggesting an apoptotic cell death. (1995) (25)
First Results from FACT - An Open-Label, Randomized Phase III Study Investigating Loading Dose of Fulvestrant Combined with Anastrozole Versus Anastrozole at First Relapse in Hormone Receptor Positive Breast Cancer (2009) (25)
Outpatient treatment with subcutaneous histamine dihydrochloride in combination with interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma: results of an open single-armed multicentre phase II study. (2002) (25)
Prevention and therapy of radiation-induced bowel discomfort. (1992) (25)
High-grade astrocytoma treated concomitantly with estramustine and radiotherapy (2006) (25)
Bumetanide annihilation of amphotericin B-induced apoptosis and cytotoxicity is due to its effect on cellular K+ flux. (2001) (25)
Verotoxin-1 induction of apoptosis in Gb3-expressing human glioma cell lines (2006) (25)
Genetic variations in EGF and EGFR and glioblastoma outcome (2010) (25)
The response of Dunning R3327 prostatic adenocarcinoma to IL-2, histamine and radiation. (1998) (25)
Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types (2015) (24)
Inhibitory Effects of Castration in an Orthotopic Model of Androgen-Independent Prostate Cancer Can Be Mimicked and Enhanced by Angiogenesis Inhibition (2006) (24)
Estramustine inhibits monocyte phagocytosis (1988) (24)
Radiologic progression of glioblastoma under therapy—an exploratory analysis of AVAglio (2018) (24)
Cellular potassium ion deprivation enhances apoptosis induced by cisplatin. (2004) (24)
Trophic effect of the sympathetic nervous system on the early development of the rat parotid gland: A quantitative ultrastructural study (1981) (23)
A Specialist Nurse as a Resource for Family Members to Patients With Brain Tumors: An Action Research Study (2008) (23)
Secretory behavior and ultrastructural changes in mouse gallbladder principal cells after stimulation with cholinergic and adrenergic drugs: A morphometric study (1979) (23)
Fractionated irradiation and late changes in rat parotid gland: effects on the number of acinar cells, potassium efflux, and amylase secretion. (1993) (23)
The effect of estramustine on microtubuli is different from the direct action via oxygen radicals on DNA and cell membrane. (1990) (22)
Quantitative structural analysis and the secretory behaviour of the rat parotid gland after long and short term isoprenaline treatment. (1979) (22)
Time- and dose-related changes in the expression of substance P in salivary glands in response to fractionated irradiation. (1995) (22)
Effects of estramustine on DNA and cell membrane in malignant glioma cells. (1991) (22)
Early morphological detection of estramustine cytotoxicity measured as alteration in cell size and shape by a new technique of microperifusion. (1991) (22)
Tobacco smoke exposure suppresses radiation-induced inflammation in the lung: a study of bronchoalveolar lavage and ultrastructural morphology in the rat. (1993) (22)
A mast cell secretagogue, compound 48/80, prevents the accumulation of hyaluronan in lung tissue injured by ionizing irradiation. (1990) (21)
Do we really know who has an MGMT methylated glioma? Results of an international survey regarding use of MGMT analyses for glioma (2019) (21)
Lrig2 and Hpse2, mutated in urofacial syndrome, pattern nerves in the urinary bladder (2019) (21)
beta 1- and beta 2-adrenoceptor agonists have different effects on rat parotid acinar cells. (1982) (21)
Suppression of matrix metalloproteinase-2-mediated cell invasion in U87MG, human glioma cells by anti-microtubule agent: in vitro study. (1998) (21)
Radiation-induced increase in hyaluronan and fibronectin in bronchoalveolar lavage fluid from breast cancer patients is suppressed by smoking. (1992) (21)
Inhibition of growth of HeLa cell tumours in nude mice by 125I-labeled anticytokeratin and antiPLAP monoclonal antibodies. (1991) (21)
Patient-reported experiences on supportive care strategies following the introduction of the first Swedish national cancer strategy and in accordance with the new patient act (2017) (21)
Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer (2009) (20)
Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma. (1994) (20)
Uptake, metabolism and antiproliferative effect of estramustine phosphate in human glioma cell lines. (1989) (20)
VEGF and tPA co-expressed in malignant glioma. (1997) (20)
Doxorubicin and epirubicin iron-induced generation of free radicalsIn vitro. A comparative study (1987) (20)
Effects of neonatal sympathetic denervation on amylase secretion in the adult rat parotid gland: Difference in β1- and β2-adrenoceptor response (1981) (19)
Correlation of molecular subtypes with survival in AVAglio (bevacizumab [Bv] and radiotherapy [RT] and temozolomide [T] for newly diagnosed glioblastoma [GB]). (2014) (19)
Metabolic Manipulation of Glioblastoma in Vivo by Retrograde Microdialysis of L-2, 4 Diaminobutyric Acid (DAB) (2006) (19)
Ultrastructural morphometry of parotid acinar cells following fractionated irradiation. (1997) (19)
The creation of hope in patients with lung cancer (2014) (19)
Estramustine potentiates the effects of irradiation on the dunning (R3327) rat prostatic adenocarcinoma (1994) (18)
Daily-diary evaluated side-effects of conformal versus conventional prostatic cancer radiotherapy technique. (1997) (18)
Beneficial effects of sucralphate in radiation induced diarrhea. An open randomized study in gynecological cancer patients. (1990) (18)
Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion--a randomised study. (1995) (18)
Cisplatin-induced apoptosis of mesothelioma cells is affected by potassium ion flux modulator amphotericin B and bumetanide. (2001) (18)
Maximum Tolerated Dose and Pharmacokinetics of Paclitaxel Micellar in Patients with Recurrent Malignant Solid Tumours: A Dose-Escalation Study (2019) (18)
Mucin in gall bladder bile of gall stone patients: influence of treatment with chenodeoxycholic acid and ursodeoxycholic acid. (1988) (18)
Return to work following meningioma surgery: a Swedish nationwide registry-based matched cohort study (2019) (17)
Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age. (2009) (17)
CASP8 D302H and meningioma risk: an analysis of five case-control series. (2009) (17)
A protein interaction network centered on leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1) regulates growth factor receptors (2018) (17)
Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer (2014) (17)
Quantitative ultrastructural studies of gall bladder epithelium in gall stone free subjects and patients with gall stones. (1990) (17)
Enhanced Expression of Neuropeptides in Human Breast Cancer Cell Lines Following Irradiation (1998) (16)
Ultrastructural morphometry and secretory behavior of acinic cell carcinoma (1985) (16)
Does sucralfate reduce radiation-induced diarrhea? (1987) (16)
Effects of estramustine and its constituents on human malignant glioma cells. (1990) (16)
Cardiac hypertrophy and decreased high-density lipoprotein cholesterol in Lrig3-deficient mice. (2016) (15)
Postoperative neoadjuvant temozolomide before radiotherapy versus standard radiotherapy in patients 60 years or younger with anaplastic astrocytoma or glioblastoma: a randomized trial (2017) (15)
Mammaglobin and lipophilin B expression in breast tumors and their lack of effect on breast cancer cell proliferation. (2008) (15)
Acquisition of Cisplatin-resistance in Malignant Mesothelioma Cells Abrogates Na+,K+,2Cl-;-cotransport Activity and Cisplatin-induced Early Membrane Blebbing (2008) (15)
Systematic Pathway Enrichment Analysis of a Genome-Wide Association Study on Breast Cancer Survival Reveals an Influence of Genes Involved in Cell Adhesion and Calcium Signaling on the Patients’ Clinical Outcome (2014) (15)
Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas (2005) (15)
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placebo (2018) (15)
Further Confirmation of Germline Glioma Risk Variant rs78378222 in TP53 and Its Implication in Tumor Tissues via Integrative Analysis of TCGA Data (2015) (15)
Adrenoceptor‐mediated responses in human skin studied by iontophoresis (1984) (15)
P34 Prognostic value of vascular endothelial growth factor protein in node-negative breast cancer (1998) (14)
Return to work following diagnosis of low-grade glioma (2020) (14)
Acute side effects after dose-escalation treatment of prostate cancer using the new urethral catheter BeamCath technique. (2001) (14)
The Antimicrotubule Drug Estramustine but not Irradiation Induces Apoptosis in Malignant Glioma Involving AKT and Caspase Pathways (2004) (14)
β1‐and β2‐adrenoceptor‐mediated secretion of amylase from incubated rat parotid gland (1984) (14)
Interactions between anticancer drugs and other clinically used pharmaceuticals. A review. (1989) (14)
PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status (2016) (14)
The prognostic value of pre-treatment thrombocytosis in two cohorts of patients with non-small cell lung cancer treated with curatively intended chemoradiotherapy. (2017) (14)
Glycoprotein tumour markers in head and neck neoplasms —a consecutive study on CA-50, CA 19-9, and CEA (1988) (14)
Effects of Amifostine on Cisplatin Induced DNA Adduct Formation and Toxicity in Malignant Glioma and Normal Tissues in Rat (1999) (14)
Does smoking protect against radiation-induced pneumonitis? (1989) (14)
Phase III Trial of Bevacizumab Added to Standard Radiotherapy and Temozolomide for Newly Diagnosed Glioblastoma: Final Progression-Free Survival and Preliminary Overall Survival Results from AVAglio (PL02.002) (2013) (14)
Effects of tobacco-smoke on radiation-induced pneumonitis in rats. (1992) (14)
Effects of cisplatin and amphotericin B on DNA adduct formation and toxicity in malignant glioma and normal tissues in rat. (1997) (14)
Inhibition of the epidermal growth factor receptor enhances castration‐induced prostate involution and reduces testosterone‐stimulated prostate growth in adult rats (2007) (14)
Determining medical decision-making capacity in brain tumor patients: why and how? (2020) (13)
STUDIES ON PAROTID SALIVA IN CYSTIC FIBROSIS (1982) (13)
EGFR Gene Variants Are Associated with Specific Somatic Aberrations in Glioma (2012) (13)
Differences in dopamine- and noradrenaline-induced amylase release from the rat parotid gland. (1985) (13)
Radiosensitizing effect of estramustine in malignant gliomain vitro andin vivo (2005) (13)
No Evidence for Increased Brain Tumour Incidence in the Swedish National Cancer Register Between Years 1980-2012 (2019) (13)
LMO7 and LIMCH1 interact with LRIG proteins in lung cancer, with prognostic implications for early-stage disease. (2018) (13)
Healthcare resource use, comorbidity, treatment and clinical outcomes for patients with primary intracranial tumors: a Swedish population-based register study (2017) (13)
DNA-repair gene variants are associated with glioblastoma survival (2012) (13)
European Association of Neuro-Oncology (EANO) Guidelines for Treatment of Primary Central Nervous System lymphoma (PCNSL). (2022) (12)
Developmental influences of the sympathetic nervous system on rat parotid gland (1985) (12)
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment (2006) (12)
Tumor blood flow and the cytotoxic effects of estramustine and its constituents in a rat glioma model. (1997) (12)
The Effect of Long‐Term Variation in Sympathetic Activity on Testicular Morphology in Immature Rats (2009) (12)
Apoptotic tumor cell death induced by estramustine in patients with malignant glioma. (1998) (12)
Biomarker (BM) evaluations in the phase III AVAglio study of bevacizumab (Bv) plus standard radiotherapy (RT) and temozolomide (T) for newly diagnosed glioblastoma (GBM). (2013) (12)
Some ultrastructural features of acinic cell carcinoma (1977) (12)
Dopamine actions in vitro on enzyme and electrolyte secretion from normal and sympathectomized rat parotid glands. (1988) (12)
Bombesin-like immunoreactivity in the rat larynx: increase in response to irradiation (1995) (12)
Fractionated irradiation and early changes in noradrenaline induced potassium efflux (86Rb+) in rat parotid gland. (1992) (12)
Short-Term Surgical Outcome for Vestibular Schwannoma in Sweden: A Nation-Wide Registry Study (2019) (12)
Rapid induction of long-lasting drug efflux activity in brain vascular endothelial cells but not malignant glioma following irradiation (2002) (12)
PHASE-CONTRAST MICROSCOPY STUDIES OF EARLY CISPLATIN-INDUCED MORPHOLOGICAL CHANGES OF MALIGNANT MESOTHELIOMA CELLS AND THE CORRESPONDENCE TO INDUCED APOPTOSIS (2008) (12)
[Registration on regional basis of patients with primary brain tumors. Regional differences disclosed]. (2007) (12)
PET response and tumor stabilization under erlotinib and bevacizumab treatment of an intracranial lesion non-invasively diagnosed as likely chordoma. (2011) (11)
Pharmacological modulation of lung cancer cells for potassium ion depletion. (2005) (11)
AVAglio: A phase III trial of bevacizumab added to standard radiotherapy and temozolomide in patients with newly diagnosed glioblastoma. (2011) (11)
Effects of chronic stimulation of salivary gland beta-adrenoceptors on saliva composition and caries development in the rat. (1989) (11)
Irradiation Induces Marked Immunohistochemical Expression of Vasoactive Intestinal Peptide in Colonic Mucosa of Man (1999) (11)
Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer. (2011) (11)
Inhibition of the epidermal growth factor receptor enhances castration-induced prostate involution and reduces testosterone-stimulated prostate growth in adult rats. (2006) (11)
Considerable improvement in survival for patients aged 60–84 years with high grade malignant gliomas – Data from the Swedish Brain Tumour Population-based Registry (2013) (11)
The Genetic Architecture of Gliomagenesis–Genetic Risk Variants Linked to Specific Molecular Subtypes (2019) (10)
The importance of an intact sympathetic innervation for the differentiation of the beta-adrenoceptor subtypes in the rat parotid gland. (1982) (10)
Sucralfate: prophylaxis of mucosal damage during cancer therapy. (1995) (10)
Iontophoretic study of skin vessel reactivity in atopic dermatitis and its correlation to serum IgE levels. (1988) (10)
Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival (2011) (10)
Distribution of estramustine in the BT4C rat glioma model (1998) (10)
Characterization of dopamine-induced potassium efflux in rat parotid acinar cells. (1988) (10)
Clinical value of using serological cytokeratins as therapeutic markers in thoracic malignancies. (2007) (10)
Regeneration of parotid acinar cells after high radiation doses. A morphological study in rat. (1995) (10)
Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma (2013) (10)
World Congress Integrative Medicine & Health 2017: part two (2017) (9)
Managing side-effects in radiotherapy with regard to the gastrointestinal tract. (1988) (9)
VIP in the rat parotid gland in response to irradiation (1997) (9)
Effects of estrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC‐3) in vitro (1995) (9)
Bombesin-like peptide is present in duct cells in salivary glands: studies on normal and irradiated animals (1997) (9)
Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study (2021) (9)
Rat salivary gland function after fractionated irradiation. (1997) (9)
LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes (2021) (9)
Dynamics of beta adrenoceptor induced amylase release and cyclic AMP accumulation in the guinea pig submandibular gland. (1979) (9)
Incidence trends in high-grade primary brain tumors in males and females. (2017) (9)
Early symptoms and sensations as predictors of lung cancer: a machine learning multivariate model (2019) (9)
Functional germline variants in driver genes of breast cancer (2017) (9)
Access to supportive care during and after cancer treatment and the impact of socioeconomic factors (2018) (9)
Alterations of tumour cells, stroma and apoptosis in rat prostatic adenocarcinoma following treatment with histamine, interleukin-2 and irradiation. (1999) (9)
Irradiation influences the expression of substance P and enkephalin in the rat larynx (2004) (9)
Response in shape and size of individual p31 cancer cells to cisplatin and ouabain: a computerized image analysis of cell halo characteristics during continuous perfusion. (2000) (9)
Total prevention of taxoid-induced alopecia by a new model of cold cap (dignitana) (1999) (9)
Iontophoretic study of adrenergic and cholinergic skin vessel reactivity in normal ageing and Alzheimer's disease. (1987) (9)
Secretory behavior and ultrastructural changes in mouse gallbladder principal cells after stimulation with cholinergic and adrenergic drugs. A morphometric study. (1979) (8)
Computerized detection of morphological changes to glioma cells during estramustine and ion-channel blocker perifusion. (1997) (8)
Effects of antimicrobial drugs on the cytotoxicity of epirubicin, bleomycin, estramustine and cisplatin. (1991) (8)
Induction of Apoptosis in Resistant Glioma Cells by Synthetic Caspase-Activation (2004) (8)
Effects of fractionated irradiation on the cytoskeleton and basal lamina in parotid glands--an immunohistochemical study. (1998) (8)
The effects of clinical and sociodemographic factors on survival, resource use and lead times in patients with high-grade gliomas: a population-based register study (2018) (8)
Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in vitro. (2001) (8)
Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study (2019) (8)
FINAL EFFICACY AND SAFETY RESULTS FROM AVAglio, A PHASE III TRIAL OF BEVACIZUMAB (BEV) PLUS TEMOZOLOMIDE (TMZ) ANDRADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA (2013) (8)
Neurosurgical patterns of care for diffuse low-grade gliomas in Sweden between 2005 and 2015 (2018) (8)
Distribution of mucosubstances in adenoid cystic carcinoma (1977) (8)
Interactions between antibiotics and antineoplastic drugs on antibacterial activity in vitro. (1990) (8)
Daily-diary Evaluated Side Effects of Dose-escalation Radiotherapy of Prostate Cancer Using the Stereotactic Beamcath®R; Technique (2003) (8)
Effects of clonidine‐induced hypotension and dopamine‐induced hypertension on blood flows in prostatic adenocarcinoma (dunning R3327) and normal tissues (1992) (7)
[Free of charge mammography gets more people to the examination. Study in Stockholm County shows good efficacy in socioeconomically disadvantaged areas]. (2014) (7)
Inhomogeneities in glycoprotein cytochemistry of secretory granules in rat-parotid acinar cells after selective beta 1-adrenoceptor stimulation. (1984) (7)
Clinical BNCT studies in Sweden (2002) (7)
Patterns of tumor progression in a phase 3 study of bevacizumab (Bv) plus radiotherapy (RT) plus temozolomide (T) for newly diagnosed glioblastoma (GB). (2014) (7)
Comparative study of demethoxydaunorubicin with other anthracyclines on generation of oxygen radicals and clonogenic survival of fibroblasts. (1989) (7)
Serotoninergic modulation of cell volume response to estramustine: an image-analysis study on perifused individual glioma cells. (1999) (7)
Adenylate cyclase toxin from Bordetella pertussis enhances cisplatin-induced apoptosis to lung cancer cells in vitro. (2005) (7)
Tumor Treating Fields for Glioblastoma Therapy During the COVID-19 Pandemic (2021) (7)
Effects of tobacco smoke on tumor growth and radiation response of Dunning R3327 prostate adenocarcinoma in rats (2000) (7)
Perivascular cell protection in vivo and increased cell survival in vitro by the antihypertensive agent carvedilol following radiation. (1999) (7)
Can alpha-tocopherol and beta-carotene supplementation reduce adverse radiation effects on salivary glands? (1995) (7)
Analysis of DNA repair gene polymorphisms and survival in low-grade and anaplastic gliomas (2011) (7)
Vandetanib alters the protein pattern in malignant glioma and normal brain in the BT4C rat glioma model. (2010) (7)
Interaction of the antiemetics ondansetron and granisetron with the cytotoxicity induced by irradiation, epirubicin, bleomycin, estramustine, and cisplatin in vitro. (1995) (7)
Tolerance to accelerated fractionation in the head and neck region. (1994) (7)
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment (2006) (7)
Ondansetron but not granisetron affect cell volume regulation and potassium ion transport of glioma cells treated with estramustine phosphate (2002) (6)
Interaction between antibiotics and antineoplastic drugs on antibacterial activity in-vitro - estramustine phosphate sensitizes pneumococci to amikacin. (1994) (6)
Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences? (2002) (6)
A review of dose-dense temozolomide alone and in combination with bevacizumab in patients with first relapse of glioblastoma. (2012) (6)
The Bleb Formation of the Extracellular Pseudopodia; Early Evidence Of Microtubule Depolymerization by Estramustine Phosphate in Glioma Cell; In Vitro Study (2001) (6)
Estramustine binding protein in primary tumours and metastases of malignant melanoma (1994) (6)
Estramustine in malignant glioma (1996) (6)
Disparities in colorectal cancer between Northern and SouthernSweden – a report from the new RISK North database (2018) (6)
Irradiation-induced effects on mast cells, neuropeptides, and atrial natriuretic peptide in the rat heart and lung: bases for further studies. (2001) (6)
LRIG1 gene copy number analysis by ddPCR and correlations to clinical factors in breast cancer (2019) (6)
Ultrastructural changes in rat parotid acinar cells after selective beta 1-adrenoceptor agonist treatment. (1983) (6)
Characterization of the rat parotid beta-adrenoceptor. (1981) (6)
Effect of Increased Radiotoxicity on Survival of Patients with Non-small Cell Lung Cancer Treated with Curatively Intended Radiotherapy. (2015) (6)
Estramustine-binding protein in meningioma (1999) (6)
Epirubicin cytotoxicity but not oxygen radical formation is enhanced by four different antiemetics (1989) (5)
Fertility-related information received by young women and men with cancer – a population-based survey (2021) (5)
Isoflurane—A Study of Its Adrenoceptor Interaction in the Isolated Rat Parotid Gland (1986) (5)
CLIN-ONGOING CLINICAL TRIALS (2012) (5)
Malignant cerebral glioma. Patients' awareness of prognosis may be confounded by successful coping mechanisms. (1997) (5)
The iCycler iQ detection system for evaluating reference gene expression in normal human tissue (2002) (5)
Diverging effects of 5-HT3 receptor antagonists ondansetron and granisetron on estramustine-inhibited cellular potassium transport. (2001) (5)
Interleukin-2-induced growth inhibition of prostatic adenocarcinoma (Dunning R 3327) in rats (2004) (5)
HEALTH-RELATED QUALITY OF LIFE (HRQOL) ANALYSES IN THE AVAGLIO STUDY, A RANDOMIZED, PLACEBO-CONTROLLED PHASE III TRIAL OF BEVACIZUMAB, TEMOZOLOMIDE AND RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA (2013) (5)
Prognostic implication of estramustine-binding protein in astrocytoma. (1995) (5)
Impact of meningioma surgery on use of antiepileptic, antidepressant, and sedative drugs: A Swedish nationwide matched cohort study (2021) (5)
Reproducibility and geometric accuracy of the fixster system during hypofractionated stereotactic radiotherapy (2008) (5)
LRIG1 negatively regulates RET mutants and is downregulated in thyroid cancer (2018) (5)
Swedish Lung Cancer Radiation Study Group: Predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer (2012) (5)
Interaction between cytostatics and nutrients (1991) (5)
Initial cognitive impairment predicts shorter survival of patients with glioblastoma (2021) (5)
Protective effect of iron chelators on epirubicin-induced fibroblast toxicity. (1988) (5)
Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL) (2020) (5)
Enigma of a rapid introduction of antiangiogenic therapy with bevacizumab in glioblastoma – a new era in the treatment of malignant brain tumours? (2009) (5)
Dopamine increases potassium efflux in the rat parotid gland by stimulating noradrenaline release from sympathetic nerve endings (1985) (5)
Inbreeding and homozygosity in breast cancer survival (2015) (5)
Structural changes in the middle ear tissues of the rat after fractionated irradiation (2004) (5)
BI-22CORRELATION OF MOLECULAR SUBTYPES WITH OVERALL SURVIVAL (OS) IN AVAGLIO, A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB (BEV) PLUS RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) FOR NEWLY DIAGNOSED GLIOBLASTOMA (GBM) (2014) (4)
Efficacy and biomarker findings from AVaglio, a phase III trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma (2013) (4)
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiation (2022) (4)
Interleukin-2-administration intravenously and intrapleurally in a patient with primary pulmonary adenocarcinoma. Cellular responses in peripheral blood, intrapleural fluid and bronchoalveolar lavage (1993) (4)
Expression of estramustine-binding protein in ependymomas and in human and developing rat ependymal cells (2005) (4)
Residual tumor volume and change in tumor volume during adjuvant therapy to predict long-term survival in AVAglio: Phase 3 newly diagnosed glioblastoma patients treated with radiation, temozolomide, and bevacizumab or placebo. (2016) (4)
Interactions of cardiovascular drugs with the cytotoxicity induced by epirubicin and irradiation in-vitro. (1993) (4)
NEURO/MEDICAL ONCOLOGY (2013) (4)
The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer (2013) (4)
A technical device for irradiation in carcinoma of the penis. (1987) (4)
Evidence-based management of adult patients with diffuse glioma - Authors' reply. (2017) (4)
Secretory effects of 5-hydroxytryptamine following neonatal sympathectomy in rat parotid gland. (1990) (4)
Binding Sites for VIP in the Reorganizing Mucosa of the Irradiated Bowel a (1998) (4)
Boron neutron capture therapy (BNCT) for glioblastoma 4 multiforme: A phase II study evaluating a prolonged high-dose of 5 boronophenylalanine (BPA) at the Studsvik facility in Sweden (2008) (4)
Is radiation-induced degranulation of mast cells in salivary glands induced by substance P? (1998) (4)
Anomalous Effects of Disodium Cromoglycate (1981) (4)
159Influence of smoking on the development of radiation induced pneumonitis of breast cancer and oesophagus cancer patients (1996) (3)
Pharmacological interaction with quinoid antitumor drugs. (1990) (3)
[Survival in malignant gliomas has increased the last decade. Analysis of quality data]. (2012) (3)
The Expression of Vascular Endothelial Growth Factor Correlates with Mutant p 53 and Poor Prognosis in Human Breast Cancer 1 (2001) (3)
Bilateral squamous cell carcinoma of the middle ear. (1990) (3)
Single nucleotide polymorphisms in the DMBT1 promoter and the progression of breast cancer (2007) (3)
Effects of estrogens and progestogens on the membrane permeability and growth of human prostatic carcinoma cells (PC-3) in vitro. (1995) (3)
Effects of interferon-α, verapamil and dacarbazine in the treatment of advanced malignant melanoma (2003) (3)
Different effects of fractionated irradiation on potassium efflux and exocytotic amylase release. (1992) (3)
Different effects of chlorpromazine on bleomycin-and epirubicin induced cytotoxicity (1990) (3)
Predictive value of vascular endothelial growth factor (VEGF) for overall survival in estrogen receptor positive breast carcinoma (1998) (3)
Antagonistic effect of amphotericin B on carboplatin antitumor activity in human osteosarcoma xenografts (1996) (3)
Interactions between LRIG proteins and LMO7 and the expression of LMO7 in human lung cancer. (2013) (3)
Does bombesin-like peptide mediate radiation-induced anorexia and satiety? (1999) (3)
Effects of irradiation on neuropeptide expression in rat salivary gland and spinal cord (1994) (3)
How to tell cancer patients — A contribution to a theory of diagnosis-communication (1997) (2)
AT-18SURVIVAL ANALYSIS OF PATIENTS WITH A PFS EVENT WHO DID NOT RECEIVE POST-PROGRESSION THERAPY IN AVAGLIO (BEVACIZUMAB [BEV] PLUS RADIOTHERAPY [RT] AND TEMOZOLOMIDE [TMZ] FOR NEWLY DIAGNOSED GLIOBLASTOMA [GBM]). (2014) (2)
CCK- and VIP-induced glycoprotein secretion from mouse gallbladder epithelium following vagotomy: a quantitative electron microscopic study. (1989) (2)
Abstract 1133: LRIG2 promotes PDGF induced experimental glioma (2011) (2)
REMOVED: Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA). (2006) (2)
Radiotherapy and Meningioma (2013) (2)
Effects of IL-2 treatment on different compartments of the irradiated rat lung analysed by bronchoalveolar lavage and lung tissue morphology. (1995) (2)
Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy—a retrospective analysis of a register-based patient cohort (2020) (2)
Chronic propranolol treatment affects parietal cells of the developing rat gastric mucosa. (1984) (2)
Baseline plasma matrix metalloproteinase 9 (MMP9) to predict overall survival (OS) benefit from bevacizumab (BEV) in newly diagnosed glioblastoma (GBM): Retrospective analysis of AVAglio. (2016) (2)
Is the modality of the supersensitivity after sympathectomy age and duration dependent? (1984) (2)
Glycoprotein secretion from mouse gallbladder principal cells after chronic variation in parasympathetic activity. A morphometric study after vagotomy and cholinergic superstimulation. (1985) (2)
Metoclopramide inhibits the cytotoxicity of cisplatin and enhances the cytotoxicity of epirubicin. (1995) (2)
Acetaminophen protection against estramustine-induced cytotoxicity on cultured fibroblasts. (1998) (2)
A Study on Cancer Patients in the Region of Stockholm by Linking Data from Multiple Sources (2015) (2)
Non-specific secretory supersensitivity in rat parotid gland following neonatal sympathetic denervation (1988) (2)
Efficacy of a novel device for cryoprevention of oral mucositis: a randomized, blinded, multicenter, parallel group, phase 3 trial (2021) (2)
Role of Non-Taxane-Containing Chemotherapy in Advanced Non-Small Cell Lung Cancer (2006) (2)
Estramustine-binding Protein in Malignant Glioma in Rat (2000) (2)
Cancer in young adulthood – classifying the intensity of treatment (2022) (2)
ME-12THE TUMOR SUPPRESSOR LRIG1 IS DOWNREGULATED BY HYPOXIA AND REGULATES GLIOBLASTOMA CELL INVASION (2014) (2)
Irradiation-induced effects on the innervation of rat salivary glands: Changes in enkephalin- and bombesin-like immunoreactivity in ganglionic cells and intraglandular nerve fibers (1993) (2)
Effects of neonatal sympathetic denervation on amylase secretion in the adult rat parotid gland: difference in beta 1- and beta 2-adrenoceptor response. (1982) (2)
QUANTITATIVE ULTRASTRUCTURAL CHANGES IN RAT PAROTID ACINAR CELLS AFTER LONG-TERM TREATMENT WITH SELECTIVE β-ANDRENOCEPTOR AGONISTS* (1981) (1)
Clinical outcomes and economic burden for bladder cancer patients: An analysis from a Swedish cancer registry. (2020) (1)
Sex-specific glioma genome-wide association study identifies new risk locus at 3p21.31 in females, and finds sex-differences in risk at 8q24.21 (2018) (1)
Radiologic progression types are treatment specific: An exploratory analysis of a phase 3 study of bevacizumab plus radiotherapy plus temozolomide for patients with newly diagnosed glioblastoma (AVAglio). (2016) (1)
Decreased peripheral β-adrenergic reactivity in asthmatics treated with oral β2-agonists (2004) (1)
[Register for new drugs in cancer care provides a picture of how the drugs are used in the daily clinical practice]. (2017) (1)
Overview of Arterial Thromboembolic Events (ATEs) in AVAglio, a Randomized, Placebo-controlled Phase III Trial of Bevacizumab, Radiotherapy and Temozolomide (BEV+RT/TMZ) for Newly Diagnosed Glioblastoma (S22.003) (2014) (1)
LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT–RCR and immunohistochemical analysis (2004) (1)
Reply to T.J. Kruser et al. (2016) (1)
P02.02 A Complete Nation-Based Registration Ensures Equal and Optimal Management of Primary Brain Tumors Patients (2016) (1)
[Modified cost-benefit analysis takes equity into consideration. Treatment of brain tumors is more cost-effective than hip replacement]. (1999) (1)
NEOADJUVANT TEMOZOLOMIDE FOR GRADE III AND IV ATROCYTOMA: A RANDOMIZED PHASE II STUDY in NEURO-ONCOLOGY, vol 12, issue , pp 39-40 (2010) (1)
Mast-cell frequency within tumor correlates to the stage of tongue cancer. (1994) (1)
P01.151 Gender differences in glioma - findings from the Swedish National Quality Registry for Primary Brain Tumors (2018) (1)
Distribution of estramustine-binding protein during postnatal development of rat brain (2001) (1)
Incidence Rates in Low-Grade Primary Brain Tumors: Are There Differences Between Men and Women? A Systematic Review (2016) (1)
[Interactions between cytostatic agents and other drugs]. (1990) (1)
Radiosensitizing biological modifiers enhancing efficacy in non-small-cell lung cancer treated with radiotherapy (2013) (1)
CHLORPROMAZINE ENHANCEMENT OF EPIRUBICIN CYTOTOXITY IN VITRO: EFFECTS ON PLASMA MEMBRANE AND DNA DAMAGE (1992) (1)
Effects of interferon-alpha, verapamil and dacarbazine in the treatment of advanced malignant melanoma. (2003) (1)
The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy. (2012) (1)
AT-17RE-ANALYSIS OF PFS/RESPONSE USING ORIGINAL MACDONALD CRITERIA AND RESPONSE EVALUATION CRITERIA IN SOLID TUMORS IN THE PHASE III AVAGLIO STUDY OF BEVACIZUMAB PLUS RADIOTHERAPY AND TEMOZOLOMIDE IN NEWLY DIAGNOSED GLIOBLASTOMA (2014) (1)
Interaction between amphotericin B, carboplatin, and radiation in human osteosarcoma xenografts in nude mice. (1996) (1)
P16.02ADC TEXTURE - AN IMAGING BIOMARKER FOR HIGH GRADE GLIOMA? (2014) (1)
Beta 1- and beta 2-adrenoceptor-mediated secretion of amylase from incubated rat parotid gland. (1984) (1)
Modulation of serous salivary gland function by the sympathetic nervous system : a biochemical and ultrastructural study with special reference to β-adrenoceptor subtypes (1981) (1)
Novel agents in the treatment of non-small cell lung cancer: implications for neoadjuvant chemotherapy? (2005) (1)
Amiloride but not bumetanide protects against the cytotoxic effects of estramustine and bleomycin in cultured fibroblasts. (1992) (1)
It is not just about molecules! Optimal cancer care for the future needs more research on external factors (2020) (1)
Primary Glioblastoma Treated With Boron Neutron Capture Therapy-Evaluation Of A Prolonged High Dose Of Boronophenylalanine (Bpa) (2008) (1)
Brief report : acquisition of cisplatin-resistance in malignant mesothelioma cells deregulates pro-apoptotic BH3-only proteins (2008) (1)
[Hypofractionation. A method for stereotaxic radiation of major brain lesions with linear accelerator]. (1993) (1)
LRIG1 amplification in breast cancer. (2004) (1)
Letter: Comment on Weitzner and Meyers (1998) (1)
274 Estramustine (EAM) induces apoptosis in malignant human and rat glioma but not in normal brain tissue (1995) (1)
Distribution of estramustine in the BT 4 C rat glioma model (1)
Survival in renal cell carcinoma (RCC)— A randomised evaluation of tamoxifen versus interleukin-2, α-interferon (leukocyte) and tamoxifen (1997) (1)
SYMPTOM MANAGEMENT/QUALITY OF LIFE (2013) (1)
Intra-and inter-individual heterogeneity in exon 2 of the MDR1 gene in primary breast carcinoma and healthy individuals. (1997) (1)
Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study (2022) (1)
K+-efflux modulation of cisplatin-induced apoptosis and cytotoxicity to cultured mesothelioma cells (1999) (1)
513Does an increased content of bombesin-like peptide in salivary glands after irradiation lead to satiety and anorexia? (1996) (0)
Anomalous effects of disodium cromoglycate. A study on two secretory systems. (1981) (0)
NIMG-84. TUMOR LOCATION IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS. (2017) (0)
Correction: Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study (2022) (0)
Socioeconomic status and concomitant diseases in patients with prostate cancer. (2014) (0)
BTC1.01 International survey regarding use of MGMT analyses for glioma (2018) (0)
Key Word and Full-Text Search Radiotherapy and Meningioma (2017) (0)
A high correlation between mutant p53 and increased expression of vascular endothelial growth factor (VEGF), combining those markers indicates poor effect by adjuvant tamoxifen in ER positive patients (1999) (0)
Promising results of multi-intensified treatment of small-cell lung cancer (SCLC). (2016) (0)
Beta-adrenoceptor stimulation increases the pH of parotid acinar cells. (1987) (0)
β‐adrenoceptor stimulation increases the pH of parotid acinar cells (1987) (0)
CMET-26. PERIOPERATIVE IMAGING OF BRAIN METASTASES: A EUROPEAN ASSOCIATION OF NEURO-ONCOLOGY (EANO) YOUNGSTERS SURVEY (2018) (0)
Correlation o f V ascular E ndothelial G rowth F actor C ontent With R ecurrences, S urvival, a nd F irst R elapse S ite i n Primary N ode-Positive B reast C arcinoma A fter Adjuvant T reatment (2013) (0)
Enhancement of radiation response of Dunning R3327 prostatic adenocarcinoma by IL-2 and histamine (1997) (0)
501 Is smoking a confounding factor when evaluating cancer treatment? Effects of smoking on radiation-induced pneumonitis (1997) (0)
Brain Tumors - Prognostic and Predictive Markers (2009) (0)
BASELINE PLASMA MATRIX METALLOPROTEINASE 9 (MMP9) PREDICTS OVERALL SURVIVAL (OS) BENEFIT FROM BEVACIZUMAB INDEPENDENTLY OF MOLECULAR SUBTYPES IN NEWLY DIAGNOSED GLIOBLASTOMA : RETROSPECTIVE ANALYSIS OF AVAglio (2016) (0)
CHANGES IN RAT PAROTID GLAND AMYLASE SECRETION AND cAMP LEVELS UNDER VARIED CONDITIONS OF β-ADRENOCEPTOR ACTIVITY* (1981) (0)
LRIG1 amplification in breast cancer (2004) (0)
Genetic variants in EGF, EGFR, ERBB2, LRIG2, LRIG3 and meningioma risk (2013) (0)
COVD-17. TUMOR TREATING FIELDS FOR GLIOBLASTOMA THERAPY DURING THE COVID-19 PANDEMIC: EXPERT CONSENSUS ON USE AND EXPERIENCE (2020) (0)
Smoking enhanced the expression of MDR-1 in rat prostatic carcinoma. (1997) (0)
[The effect of diet on the treatment of malignant diseases]. (1990) (0)
A Study on Treatment and Characteristics of Prostate Cancer Patients Using Real-World Data (2015) (0)
Communicating with the unconscious patient. (1990) (0)
Phosphoinositide 3-kinase-independent, constitutive activation of protein kinase B isoforms in malignant pleural mesothelioma cells (2008) (0)
Expression of the human LRIG genes and proteins as prognostic markers in human cancer (2012) (0)
Histamine enhanced antitumor effect of docetaxel and dacarbazine in human clear cell sarcoma xenografts in nude mice (2001) (0)
Genome-wide association study of glioma and meta-analysis (2012) (0)
[BNCT--neutron radiotherapy of brain tumors]. (2002) (0)
Differences and similarities in the expression of the epidermal growth factor receptor family and the proposed tumor suppressor LRIG1 in types of renal cell carcinoma as analyzed by quantitative real-time RT-PCR (2009) (0)
LRIG1 is a prognostic biomarker and tumor suppressor in non-small cell lung cancer (2013) (0)
[Surprising ability to handle bad news. A study of how cancer patients create hope]. (1999) (0)
Simultaneous acute myeloid leukemia and mesothelioma diagnoses in a long-term survivor of the 1984 Bhopal gas leak (0)
413 POSTER Expression of Gb3/CD77 and effect of verotoxin-1 treatment of cisplatin-resistant mesothelioma and NSCLC cells (2007) (0)
Centralisation improves survival of pancreatic cancer by increased surgical indications and resection rates – a population-based study (2020) (0)
Short-term outcome following surgery for rare brain tumor entities in adults: a Swedish nation-wide registry-based study and comparison with SEER database (2020) (0)
Health-related quality of life (HRQoL) in AVAglio, a randomized, placebo (P)-controlled phase III study of bevacizumab (B), temozolomide (T) and radiotherapy (RI) in patients (pts) with newly diagnosed glioblastoma (GBM) (2013) (0)
Diverging effects of 5-HT3 receptor antagonists on cellular potassium transport (1999) (0)
Abstract A42: Characterization of EGFR and leucine‐rich repeats and immunoglobulin‐like domain proteins (LRIG1–3) in esophageal carcinoma with emphasis on patient survival (2009) (0)
GASTRIC PARIETAL CELL CHANGES DUE TO LONG-TERM PROPRANOLOL ADMINISTRATION IN ADULT AND DEVELOPING RATS (1984) (0)
ATPS-34THE ROLE OF Lrig1 AND Lrig3 IN PDGF-INDUCED EXPERIMENTAL GLIOMA (2015) (0)
O9.03BRAIN TUMORS IN SWEDEN: DATA FROM A POPULATION BASED REGISTRY 1999-2012 (2014) (0)
Centralization Improves Survival of Pancreatic Cancer by Increased Operative Indication and Resection Rate: A Population-Based Study (2020) (0)
61 Influence of polymorphism-modified gene expression on breast cancer survival (2010) (0)
European School of Oncology First Euro-American Forum Treatment on Lung Cancer (2003) (0)
It is Now Time for a Powerful View in the Management of Lung Cancer (2002) (0)
The Addition of Bevacizumab (BEV) to Temozolomide (TMZ) and Radiation Therapy (RT) in Newly Diagnosed Glioblastoma (GBM) Improves Progression-Free Survival (PFS) Without Adding to RT Toxicity (2013) (0)
Correction: Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study (2022) (0)
Uptake andretention ofestramustine andthepresence ofestramustine binding protein inmalignant brain tumours inhumans (1993) (0)
Psychotropic and anti-epileptic drug use, before and after surgery, among patients with low-grade glioma: a nationwide matched cohort study (2021) (0)
Treatment options in elderly patients with glioblastoma - Authors' reply (2012) (0)
Changes in protein expression in experimental malignant glioma following radiotherapy (2005) (0)
RESIDUAL ENHANCING TUMOR VOLUME IS A STRONG PROGNOSTIC BIOMARKER FOR SURVIVAL IN BOTH NEWLY DIAGNOSED AND RECURRENT GBM REGARDLESS OF THERAPY : EVIDENCE FROM 1,535 PATIENTS IN SINGLE AND MULTICENTER TRIALS (2016) (0)
Abstracts for the Tenth International Conference on Brain Tumour Research and Therapy (2005) (0)
[Regional cancer centers in collaboration: The time is ripe for open reporting within pathology]. (2015) (0)
P14.09 INITIAL GLOBAL SYMPTOMS IN GLIOBLASTOMA ARE OFTEN MISINTERPRETED AND ASSOCIATED WITH SHORTER SURVIVAL (2019) (0)
Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma (2012) (0)
Proffered paper radiobiologyTime and dose-related changes in the expression of neuropeptides in salivary glands in response to ionsing irradiation (1993) (0)
[Is interleukin-2 a break-through in the immunologic treatment of cancer?]. (1990) (0)
848 Does the clinical outcome correlate to altered expression of the EGF receptor-family in renal cell carcinoma? (2003) (0)
SAFETY RESULTS FROM AVAglio, A PHASE III RANDOMIZED STUDY OF BEVACIZUMAB (BEV) PLUS STANDARD COMBINATION TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) (2013) (0)
ESTRAMUSTINE INDUCES APOPTOSIS IN MALIGNANT GLIOMA IN THE CLINICAL SITUATION (1996) (0)
Functional germline variants in driver genes of breast cancer (2017) (0)
Correction: Increased copy number at 3p14 in breast cancer (2006) (0)
The Swedish Brain Tumour Study Group in the Framework of a New “Patient in the Focus of Cancer Care” in Sweden (2017) (0)
Isoflurane???A Study of Its Adrenoceptor Interaction in the Isolated Rat Parotid Gland (1986) (0)
620 Cellular potassium ion deprivation may enhance apoptosis induced by cisplatin (2003) (0)
Analysis of VIP and CGRP Plasma Levels After Radiotherapy for Treatment of Metastasis from Prostatic Carcinoma (2000) (0)
Survival of esophageal and gastric cancer patients with adjuvant and palliative chemotherapy—a retrospective analysis of a register-based patient cohort (2020) (0)
Guest Editorial Communicating with the unconscious patient 107 (1990) (0)
729 POSTER Safety, maximum tolerated dose and pharmacokinetics of a novel micellar formulation of paclitaxel in the treatment of recurrent solid tumours – a phase I/II study (2007) (0)
Mistletoe therapy in primary and recurrent inoperable pancreatic cancer. A phase III prospective, randomized, double-blinded, multicenter, parallel group, placebo-controlled clinical trial on overall survival and health-related quality of life (MISTRAL) (2019) (0)
LRIG proteins regulate lipid metabolism via BMP signaling and affect the risk of type 2 diabetes (2021) (0)
Proteomic Analysis of Malignant Glioma Tissue Following Treatment with the Receptor Tyrosine Kinase Inhibtor ZD6474 (2008) (0)
O2214 ANTITUMOR EFFECT OF DOCETAXEL AND DACARBAZINE ENHANCED BY HISTAMINE IN HUMAN CLEAR CELL SARCOMA XENOGRAFTS IN NUDE MICE (2004) (0)
Doxorubicin and Epirubicin Generation of Free Radicals Comparative Study (1987) (0)
NIMG-53. POST-SURGICAL, RESIDUAL ENHANCING TUMOR VOLUME IS PROGNOSTIC FOR OVERALL SURVIVAL IN NEWLY DIAGNOSED GLIOBLASTOMA: EVIDENCE FROM 1,458 PATIENTS POOLED FROM INTERNATIONAL TRIALS, SINGLE INSTITUTION DATABASES, AND MULTICENTER CONSORTIUMS (2017) (0)
617 Apoptotic morphology of adherent cells in vital phase-contrast microscopy compared to scanning electron microscopy images (2003) (0)
Surveillance of drug treatments in cancer patients by database linkage. (2014) (0)
287 Interleukin-2 (IL-2)/interferon-α (IF) after initial chemotherapy — Beneficial effects in extensive small cell lung carcinoma (SCLC)? (1997) (0)
Phase I study of PKC412, a protein kinase C inhibitor, in combination with gemcitabine and cisplatin: Preliminary report of an ongoing phase I study (2000) (0)
Volume Contents (2004) (0)
Decreased peripheral beta-adrenergic reactivity in asthmatics treated with oral beta 2-agonists. (1988) (0)
354 POSTER A-toxin enhancement of cisplatin-induced apoptosis in cisplatin-resistant mesothelioma cells (2007) (0)
Evaluation of advanced MR techniques for development of early biomarkers for treatment efficacy in malignant brain tumors (2010) (0)
LRIG2 promotes PDGF induced experimental glioma (2010) (0)
Studies on the plasticity of substance P- and CGRP-expression in laryngeal parasympathetic neurons: Effects of vagotomy and irradiation (1993) (0)
Neurocognitive Function (NCF) Substudy and Mini-Mental State Examination (MMSE) Results from the Randomized, Placebo-Controlled Phase III AVAglio Trial of Bevacizumab (BEV) Added to Radiotherapy (RT) and Temozolomide (TMZ) for Newly Diagnosed Glioblastoma (S22.002) (2014) (0)
Increase inmastcells andhyaluronic acidcorrelates toradiation-induce d damageandloss ofserousacinar cells insalivary glands: theparotid and submandibular glands differ inradiation sensitivity (1994) (0)
GLIOBLASTOMA IN ELDERLY PATIENTS: HEALTH-RELATED QUALITY OF LIFE (HRQOL) IN A RANDOMIZED TRIAL COMPARING 6-WEEKS OF TADIOTHERAPY (RT) VS HYPOFRACTIONATED RT OVER 2 WEEKS VS TEMOZOLOMIDE CHEMOTHERAPY (TMZ) in NEURO-ONCOLOGY, vol 12, issue , pp 18-19 (2010) (0)
Irradiation influences the expression of bombesin-like peptide in the rat larynx (1994) (0)
Increased peripheral alpha-adrenoceptor response in allergic asthmatics. (1988) (0)
P01.082 International survey regarding use of MGMT analyses for glioma (2018) (0)
Time-related changes in the expression of neuropeptides in salivary glands in response to ionising irradiation (1993) (0)
Stage I / II Breast Cancer Locus Increases Risk of Early and Late Relapse of LRIG 1 Loss of Updated (2014) (0)
P15.14DEVELOPING PATIENT REPORTED OUTCOME MEASURES (PRO) FOR IMPLEMENTATION IN THE SWEDISH NATIONAL QUALITY REGISTER FOR PRIMARY BRAIN TUMORS (2014) (0)
[Talking to the comatose patient!]. (1989) (0)
Lrig2 knock-out mice have increased mortality, impaired fertility and transiently reduced body weight (2010) (0)
Tobacco smoke decreases radiation-induced pneumonitis A bronchoalveolar lavage and morphological study in man and rat (1993) (0)
Do young adults with cancer receive information about treatment-related impact on sex life? Results from a population-based study. (2023) (0)
P-604 Radiotherapy with daily Taxol in locally advanced NSCLC (2005) (0)
[SBU is wrong on radiotherapy of brain tumors. Early postoperative therapy prolongs the symptom-free period]. (1997) (0)
Efficacy and safety of bevacizumab (By) plus standard combination temozolomide (T) and radiotherapy (RT) in newly diagnosed glioblastoma : final results from AVAglio (2013) (0)
LBA37 A blinded, randomized, parallel group, comparative investigation of a novel device (Cooral) for cryoprevention of oral mucositis (2020) (0)
Treatment with the angiogenesis inhibitor vandetanib (ZD6474) alters proteomic pattern (2009) (0)
Mammaglobin and lipophilin B expression in breast cancer and their lack of effects on breast carcinoma cell proliferation rates (2005) (0)
Volume Contents (2004) (0)
LMO7 interacts with LRIG proteins, and is a negative prognostic marker in lung cancer (2013) (0)
955: Functional germline variants in driver genes of breast cancer (2014) (0)
Irradiation induces changes in neuropeptide expression in the rat submandibular gland (1992) (0)
[Survival increases for all cancer diagnoses - but inequality persists]. (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roger Henriksson,?

Roger Henriksson, is affiliated with the following schools:

Roger Henriksson,'s Academic­Influence.com Rankings

Why Is Roger Henriksson, Influential?

Roger Henriksson,'s Published Works

Published Works

What Schools Are Affiliated With Roger Henriksson,?

Roger Henriksson,'s AcademicInfluence.com Rankings